A comparison of 100 cases of human hepatocellular carcinoma revealed that 71% showed overexpression of NDUFA4L2 and had a lower 5-year overall survival rate as compared to controls. This evidence concerns the gene COXFA4L2 and hepatocellular carcinoma.